The briefing
A report highlights research into how tyrosine hydroxylase and adrenergic nerve signaling relate to triple‑negative breast cancer, a subtype lacking hormone and HER2 targets. The work seeks mechanistic insights that could inform future treatment strategies beyond chemotherapy.
Original headline
Tyrosine Hydroxylase Links Adrenergic Nerves to Triple